chr3-50364714-C-G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7

The NM_006030.4(CACNA2D2):​c.3384G>C​(p.Pro1128Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000717 in 1,395,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. P1128P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

CACNA2D2
NM_006030.4 synonymous

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.40

Publications

1 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP7
Synonymous conserved (PhyloP=-1.4 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006030.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
NM_006030.4
MANE Select
c.3384G>Cp.Pro1128Pro
synonymous
Exon 38 of 38NP_006021.2Q9NY47-2
CACNA2D2
NM_001174051.3
c.3405G>Cp.Pro1135Pro
synonymous
Exon 39 of 39NP_001167522.1Q9NY47-1
CACNA2D2
NM_001005505.3
c.3390G>Cp.Pro1130Pro
synonymous
Exon 38 of 38NP_001005505.1Q9NY47-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
ENST00000424201.7
TSL:1 MANE Select
c.3384G>Cp.Pro1128Pro
synonymous
Exon 38 of 38ENSP00000390329.2Q9NY47-2
CACNA2D2
ENST00000423994.6
TSL:5
c.3414G>Cp.Pro1138Pro
synonymous
Exon 39 of 39ENSP00000407393.2C9JVC9
CACNA2D2
ENST00000479441.1
TSL:1
c.3405G>Cp.Pro1135Pro
synonymous
Exon 39 of 39ENSP00000418081.1Q9NY47-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.17e-7
AC:
1
AN:
1395386
Hom.:
0
Cov.:
32
AF XY:
0.00000145
AC XY:
1
AN XY:
688376
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31336
American (AMR)
AF:
0.00
AC:
0
AN:
34948
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25012
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35716
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79714
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48346
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4490
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078078
Other (OTH)
AF:
0.00
AC:
0
AN:
57746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
4.0
DANN
Benign
0.60
PhyloP100
-1.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1379269800; hg19: chr3-50402145; API